This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ironwood Pharmaceuticals Inc (IRWD)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -189.62M -272.81M -72.62M -64.85M
Operating Gains/Losses 2.69M 610.00K 20.00K 7.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -23.68M -1.73M -835.00K 2.24M
(Increase) Decrease in Inventories -3.08M -11.91M -6.70M 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 2.83M
(Decrease) Increase In Payables 1.43M -11.72M 24.24M 5.09M
(Decrease) Increase In Other Current Liabilities 162.00K -2.25M -1.35M -1.13M
(Increase) Decrease In Other Working Capital -982.00K -8.02M -37.32M -45.81M
Other Non-Cash Items 48.04M 21.55M 17.57M 13.97M
Net Cash From Continuing Operations -155.57M -273.36M -69.63M -75.24M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -155.57M -273.36M -69.63M -75.24M
Sale of Property, Plant & Equipment 0.00 0.00 9.00K 4.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 200.96M 196.10M 140.76M 222.25M
Purchases of Property, Plant & Equipment -3.54M -9.59M -13.98M -9.68M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -254.00M -287.94M -96.71M -97.51M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -56.57M -101.43M 30.08M 115.06M
Issuance of Debt 0.00 175.00M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 213.17M 147.06M 89.25M 3.39M
Repayment of Long-Term Debt -2.23M -768.00K -275.00K -260.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -7.72M 0.00 0.00
Net Cash From Financing Activities 210.94M 313.58M 88.97M 3.13M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -1.19M -61.21M 49.42M 42.96M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

IRWD Ironwood Pharmaceuticals Inc

Chart of IRWD

Analysts Ratings for IRWD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

IRWD Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs